AIVITA Biomedical Announces 96% Immune Response Against SARS-CoV-2 in Phase 2 Clinical Trial of a Personalized Vaccine

IRVINE, Calif., Sept. 13, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative cell therapies, today announced results from its Phase 2 clinical study testing AIVITA’s anti-SARS-CoV-2 Vaccine Enabling Kit, which allows any minimally-equipped facility to make personalized COVID-19 vaccines during the course of 2 patient visits one week apart. The Phase … Continued

Read More

AIVITA Biomedical’s Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival

Personalized cancer vaccine increases progression-free survival (PFS) by 50% IRVINE, Calif., June 8, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM). The analysis focused on … Continued

Read More

Randomized Clinical Trial Results Confirm PleuraFlow Reduces Take Back for Bleeding in Cardiac Surgery Patients

RVINE, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery. The findings are reported by cardiac surgeons at the Montreal Heart Institute, in Montreal, Quebec, Canada in the article, “Active clearance vs conventional management of chest tubes after cardiac surgery: a … Continued

Read More

FanGraphs Baseball Hits a Home Run with MariaDB SkySQL and SkyDBA

SkySQL on GCP powers FanGraphs’ comprehensive, data-driven projections for major and minor league baseball   REDWOOD CITY, Calif. and HELSINKI – March 25, 2021 – MariaDB® Corporation today announced that popular baseball analysis site FanGraphs has drafted MariaDB SkySQL as its cloud database running on Google Cloud Platform (GCP) and SkyDBA for first-string, 24x7x365 teammate … Continued

Read More

MariaDB SkySQL Awarded Two Major 2021 Industry Honors

REDWOOD CITY, Calif. and HELSINKI – March 10, 2021 – MariaDB® Corporation today announced that its cloud database MariaDB SkySQL has won the InfoWorld Technology of the Year Awards for 2021. The awards, which identify the best and most innovative products on the IT landscape, recognized SkySQL for its ability to deliver exceptional scale and … Continued

Read More

Otsuka Pharmaceutical Development & Commercialization, Inc., and Spencer Health Solutions, Inc., Enter Agreement for Use of spencer® Smart Hub in Clinical Trials and Commercial Applications

PRINCETON, N.J. & MORRISVILLE, N.C.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development & Commercialization, Inc., and Spencer Health Solutions, Inc., today announced an agreement to jointly create a transformational patient experience using the spencer® smart hub, the world’s first at-home medication device that connects patients and their care teams through an easy-to-use, fully integrated platform. As part of the … Continued

Read More

AIVITA Biomedical’s Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival

Personalized cancer vaccine reduces risk of disease progression or death by 38% IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM). The … Continued

Read More

AIVITA Biomedical Completes Treatment of Patients in Phase 2 Clinical Trial of Glioblastoma Immunotherapy

— 94% manufacturing success rate achieved for personalized cancer immunotherapy development — IRVINE, Calif., Nov. 2, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, announced today that treatment has been completed for all 57 patients in the Phase 2 clinical trial of AV-GBM-1 in patients with glioblastoma. The … Continued

Read More

AIVITA Biomedical Publishes Review of GM-CSF History and Rationale as Vaccine Adjuvant in Melanoma Management

IRVINE, Calif., Aug. 3, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, announced today the publication of the paper, “An update on GM-CSF and its potential role in melanoma management,” in the journal Melanoma Management. Robert O. Dillman, M.D., chief medical officer at … Continued

Read More